Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation
Clinical trial NCT03925935 · COMPLETED
Trial details
- NCT number
- NCT03925935
- Sponsor
- Angiocrine Bioscience
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2020-11-18
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.